Galapagos Affirms Q4 Guidance, Lowers Full-Year Cash Burn Projections

genomeweb
360dx

Galapagos Affirms Q4 Guidance, Lowers Full-Year Cash Burn Projections

Jan 18, 2006

NEW YORK, Jan. 18 (GenomeWeb News) - Galapagos today said that it expects its fourth-quarter 2005 revenues to meet previous guidance of €7.7 million ($9.3 million), and that it expects its full-year cash burn to be lower than its guidance of €7 million.

To read the full story....

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

UK Effort to Sequence 3K Bacterial Genomes Nears Goal
People in the News: Patrick Kaltenbach, Margo Georgiadis, William Bonello, More
In Brief This Week: SeraCare; Human Longevity; CareDx; Interpace Diagnostics; and More
Single-Cell Transcriptomics Studies Draw Cell Type Maps for Complete Animal
Biotheranostics Settles False Claims Allegations With DOJ for $2M
Genetic Signatures Gets CE Mark for 'Superbugs' Kit

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Main menu